Repeatability of tumor blood flow quantification with (82)Rubidium PET/CT in prostate cancer — a test-retest study

BACKGROUND: Non-invasive tumor blood flow (TBF) quantification is a candidate approach for risk stratification and monitoring of prostate cancer patients. Validation data have recently been published on prostate TBF measurement with the widely used positron emission tomography (PET) flow tracer (82)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:EJNMMI Res
Egile Nagusiak: Jochumsen, Mads Ryø, Bouchelouche, Kirsten, Nielsen, Katrine Bødkergaard, Frøkiær, Jørgen, Borre, Michael, Sörensen, Jens, Tolbod, Lars Poulsen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2019
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6609677/
https://ncbi.nlm.nih.gov/pubmed/31273483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-019-0529-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak